An environmental risk assessment for human-use Trimethoprim in European surface waters

Antibiotics

Volumn 2, Issue 1, 2013, Pages 115-162

  Straub, Jürg Oliver ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Environmental effects; Environmental exposure; Environmental risk assessment; Europe; Surface waters; Trimethoprim

Indexed keywords

SURFACE WATER; TRIMETHOPRIM;

ACTIVATED SLUDGE; ARTICLE; AUTORADIOGRAPHY; BAYES THEOREM; BIOACCUMULATION; BIODEGRADABILITY; ECOTOXICITY; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL IMPACT; GROWTH INHIBITION; HALF LIFE TIME; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LEMNA MINOR; LIMIT OF QUANTITATION; NITRIFICATION; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RISK ASSESSMENT; SEWAGE TREATMENT PLANT; ZEBRA FISH;

EID: 84921521933     PISSN: None     EISSN: 20796382     Source Type: Journal    
DOI: 10.3390/antibiotics2010115     Document Type: Article

References (166)

1. Straub, J. O.; Hutchinson, T. H. Environmental Risk Assessment for Human Pharmaceuticals: The Current State of International Regulations. In Human Pharmaceuticals in the Environment: Current and Future Perspectives. Emerging Topics in Ecotoxicology 4; Brooks, B. W., Huggett, D. B., Eds.; Springer: New York, NY, USA, 2012; pp. 17-48.
2. Roche Safety Data Sheet Trimethoprim, version 02. 11. 2011; F. Hoffmann-La Roche Ltd: Basle, Switzerland, 2011. Available online: http://www. roche. com/responsibility/environment/safety_data_sheets/safety_data_sheets-row. htm (accessed on 25 February 2013).
3. Clarke's Analysis of Drugs and Poisons. Subscription online version: https://www. medicinescomplete. com/mc/login. htm (accessed on 12 March 2013).
4. WHO Collaborating Centre for Drug Statistics Methodology. ATC/DDD Codes. Norwegian Institute of Public Health: Oslo, Norway. Available online: http://www. whocc. no/atc_ddd_index/(accessed on 12 March 2013).
5. Gros, M.; Petrović, M.; Barceló, D. Development of a multi-residue analytical methodology based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters. Talanta 2006, 70, 678-690.
6. PhysProp open access online database. Available online: http://www. syrres. com/what-we-do/databaseforms. aspx?id=386 (accessed on 12 March 2013).
7. Chen, X.-Q.; Cho, S. J.; Li, Y.; Venkatesh, S. Prediction of aqueous solubility of organic compounds using a QSPR. J. Pharm. Sci. 2002, 91, 1838-1852.
8. Ran, Y.; He, Y.; Yang, G.; Johnson, J. L. H.; Yalkowsy, S. H. Estimation of aqueous solubility of organic compounds by using the general solubility equation. Chemosphere 2002, 48, 487-509.
9. Bergsjø, T.; Søgnen, E. Plasma and tissue levels of trimethoprim in the rainbow trout, Salmo gairdneri, after absorption from fresh and salt water. Acta Vet. Scand. 1980, 21, 18-25.
10. Qiang, Z.; Adams, C. Potentiometric determination of acid dissociation constants (pKa) for human and veterinary antibiotics. Water Res. 2004, 38, 2874-2890.
11. Zhu, C.; Jiang, L.; Chen, T.-M.; Hwang, K.-K. A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential. Eur. J. Med. Chem. 2002, 37, 399-407.
12. Zhao, Y.; Jona, J.; Chow, D. T.; Rong, H.; Semin, D.; Xia, X.; Zanon, R.; Spancake, C.; Maliski, E. High-throughput logP measurement using parallel liquid chromatography/ultraviolet/mass spectrometry and sample pooling. Rapid Commun. Mass Spectrom. 2002, 16, 1548-1555.
13. Boxall, A. B. A.; Fogg, L. A.; Baird, D. J.; Lewis, C.; Telfer, T. C.; Kolpin, D.; Gravell, A.; Pemberton, E.; Boucard, T. Targeted Monitoring Study for Veterinary Medicines in the Environment, Science Report: SC030183/SR; UK Environment Agency: Bristol, UK, 2005. Available online: http://www. environment-agency. gov. uk (accessed on 12 March 2013).
14. Barron, L.; Havel, J.; Purcell, M.; Szpak, M.; Kelleher, B.; Paull, B. Predicting sorption of pharmaceuticals and personal care products onto soil and digested sludge using artificial networks. Analyst 2009, 134, 663-670.
15. Liu, F.; Ying, G.-G.; Yang, J.-F.; Zhou, L.-J.; Tao, R.; Wang, L.; Zhang, L.-J.; Peng, P.-A. Dissipation of sulfamethoxazole, trimethoprim and tylosin in a soil under aerobic and anoxic conditions. Environ. Chem. 2010, 7, 370-376.
16. Lin, K.; Gan, J. Sorption and degradation of wastewater-associated non-steroidal anti-inflammatory drugs and antibiotics in soil. Chemosphere 2011, 83, 240-246.
17. Franco, A.; Trapp, S. A multimedia activity model for ionisable compounds: Validation study with 2, 4-dichlorophenoxyacetic acid, aniline and trimethoprim. Environ. Sci. Technol. 2010, 29, 789-799.
18. Halling-Sørensen, B. ERA of antibiotics: Comparison of mecillinam, trimethoprim and ciprofloxacin. J. Antimicrob. Chemother. 2000, 46, 53-58.
19. Göbel, A.; Thomsen, A.; McArdell, C. S.; Joss, A.; Giger, W. Occurrence and sorption behavior of sulfonamides, macrolides and trimethoprim in activated sludge treatment. Environ. Sci. Technol. 2005, 39, 3981-3989.
20. McArdell, C. S.; Joss, A.; Alder, A. C.; Felis, E.; Giger, W.; Göbel, A.; Löffler, D.; Siegrist, H.; Zabczynski, S.; Ternes, T. A. Sorption of pharmaceuticals and personal care products to activated sludge. Poster of the SETAC Europe 15th Annual Meeting, Lille, France, May 2005.
21. Gartiser, S.; Urich, E.; Alexy, R.; Kümmerer, K. Anaerobic inhibition and degradation of antibiotics in ISO test schemes. Chemosphere 2007, 66, 1839-1848.
22. Abegglen, C.: Joss, A.; McArdell, C. S.; Fink, G.; Schlüsener, M. P.; Ternes, T. A.; Siegrist, H. The fate of selected micropollutants in a single-house MBR. Water Res. 2009, 43, 2036-2046.
23. Radjenovic, J.; Petrovic, M.; Barceló, D. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advances membrane bioreactor (MBR) treatment. Water Res. 2009, 43, 831-841.
24. Power, E.; Quinn, B.; Brett, P.; Barron, L. Transport of pharmaceutical residues to the soil environment following biosolid enrichment. Poster of the SETAC Europe 19th Annual Meeting, Göteborg, Sweden, 31 May-4 June 2009.
25. Batt, A. L.; Kim, S.; Aga, D. S. Enhanced biodegradation of iopromide and trimethoprim in nitrifying activated sludge. Environ. Sci. Technol. 2006, 40, 7367-7373.
26. Göbel, A.; McArdell, C. S.; Joss, A.; Siegrist, H.; Giger, W. Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. Sci. Total Environ. 2007, 372, 361-371.
27. Martín, J.; Camacho-Muñoz, M. D.; Santos, J. L.; Aparicio, I.; Alonso, E. Distribution and temporal evolution of pharmaceutically active compounds alongside sewage sludge treatment. Risk assessment of sludge application onto soils. J. Environ. Manag. 2012, 102, 18-25.
28. Trapp, S.; Franco, A.; Mackay, D. Activity-based concept for transport and partitioning of ionising organcis. Environ. Sci. Technol. 2010, 44, 6123-6129.
29. Alexy, R.; Kümpel, T.; Kümmerer, K. Assessment of degradation of 18 antibiotics in the Closed Bottle test. Chemosphere 2004, 57, 505-512.
30. Bundschuh, M.; Hahn, T.; Gessner, M. O.; Schulz, R. Antibiotics as a chemical stressor affecting an aquatic decomposer-detritivore system. Environ. Sci. Technol. 2009, 28, 197-203.
31. Gröner, J. Biochemische Abbaubarkeit verschiedener Substanzen. Interner Bericht TSU/BWL; F. Hoffmann-La Roche AG, Basel, Switzerland, 16 November 1981.
32. Junker, T.; Alexy, R.; Knacker, T, Kümmerer, K. Biodegradability of 14C-labeled antibiotics in a modified laboratory scale sewage treatment plant at environmentally relevant concentrations. Environ. Sci. Technol. 2006, 40, 318-324.
33. Yu, T.-H.; Lin, A. Y.-C.; Lateef, S. K.; Lin, C.-F.; Yang, P.-Y. Removal of antibiotics and non-steroidal anti-inflammatory drugs by extended sludge age biological process. Chemosphere 2009, 77, 175-181.
34. Pérez, S.; Eichhorn, P.; Aga, D. S. Evaluating the biodegradability of sulfamethazine, sulfamethoxazole, sulfathiazole and trimethoprim at different stages of sewage treatment. Environ. Sci. Technol. 2005, 24, 1361-1367.
35. Schröder, H. F.; Tambosi, J. L.; Sena, R. F.; Moreira, R. F. P. M.; José, H. J.; Pinnekamp, J. The removal and degradation of pharmaceutical compounds during membrane bioreactor treatment. Water Sci. Technol. 2012, 65, 833-839.
36. Löffler, D.; Ternes, T. A. Determination of acidic pharmaceuticals, antibiotics and ivermectin in river sediment using liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2003, 1021, 133-144.
37. Schmidt, C. K.; Brauch, H.-J.; Jekel, M. Die Entfernbarkeit polarer Spurenstoffe in der Trinkwasseraufbereitung. Proceedings of WASSER Berlin, Berlin, Germany, 3-7 April, 2006; Wasserchemische Gesellschaft: Berlin, Germany, 2006.
38. Mohring, S. A. I.; Strzysch, I.; Reis Fernandes, M.; Kiffmeyer, T.; Tuerk, J.; Hamscher, G. Degradation and elimination of various sulfonamides during anaerobic fermentation: A promising step on the way to sustainable pharmacy? Environ. Sci. Technol. 2009, 43, 2569-2574.
39. Grote, A.; Vockel, A.; Schwarze, D.; Mehlich, A.; Freitag, M. Fate of antibiotics in food chain and environment originating from pig fattening (part 1). Fresenius Environ. Bull. 2004, 13, 1216-1224.
40. Boxall, A. B. A.; Johnson, P.; Smith, E. J.; Sinclair, C. J.; Stutt, E.; Levy, L. S. Uptake of veterinary medicines from soils into plants. J. Agric. Food Chem. 2006, 54, 2288-2297.
41. Benotti, M. J.; Brownawell, B. J. Microbial degradation of pharmaceuticals in estuarine and coastal seawater. Environ. Pollut. 2009, 157, 994-1002.
42. Ternes, T. A.; Hirsch, R. W.; Stumpf, M.; Eggert, T.; Schuppert, B. F.; Haberer, K. Nachweis und Screening von Arzneimittelrückständen, Diagnostika und Antiseptika in der aquatischen Umwelt; ESWE-Institut für Wasserforschung und Wassertechnologie GmbH: Wiesbaden, Germany, 1999.
43. Paxéus, N. A. Removal of selected non-steroidal anti-inflammatory drugs (NSAIDs), gemfobrozil, carbamazepine, beta-blockers, trimethoprim and triclosan in conventional wastewater treatment plants in five EU countries and their discharge to the aquatic environment. Water Sci. Technol. 2004, 50, 253-260.
44. Bendz, D.; Paxéus, N. A.; Ginn, T. R.; Loge, F. J. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden. J. Hazard. Mater. 2005, 122, 195-204.
45. Lindberg, R. H.; Wennberg, P.; Johansson, M. I.; Tysklind, M.; Andersson, B. A. V. Screening of human antibiotic substances and determination of weekly mass flows in five sewage treatment plants in Sweden. Environ. Sci. Technol. 2005, 39, 3421-3429.
46. Lindberg, R. H.; Olofsson, U.; Rendahl, P.; Johansson, M. I.; Tysklind, M.; Andersson, B. A. V. Behavior of fluoroquinolones and trimethoprim during mechanical, chemical and active sludge treatment of sewage water and digestion of sludge. Environ. Sci. Technol. 2006, 40, 1042-1048.
47. Paffoni, C.; Welte, B.; Gousailles, M.; Montiel, A. Nouvelles molécules mises en cause par les directives européennes: de la station d'épuration à l'usine de traitement d'eau potable. Eur. J. Water Qual. 2006, 37, 21-38.
48. Gros, M.; Petrović, M.; Barceló, D. Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the Ebro River basin (Northeast Spain). Environ. Sci. Technol. 2007, 26, 1553-1562.
49. Senta, I.; Terzić, S.; Ahel, M. Simultaneous determination of sulfonamides, fluoroquinolones, macrolides and trimpethoprim in wastewater and river water by LC-tandem-MS. Chromatographia 2008, 68, 747-758.
50. Kasprzyk-Hordern, B.; Dinsdale, R. M.; Guwy, A. L. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. Water Res. 2009, 43, 363-380.
51. Segura, P. A.; Lajeunesse, A.; Gagnon, C.; Sauvé, S. Anti-infectives in urban wastewater effluents in the province of Québec (Canada). Poster of the 16th SETAC Europe Annual Conference, Hague, The Netherlands, 7-11 May 2005.
52. Brown, K. D.; Kulis, J.; Thomson, B.; Chapman, T. H.; Mawhinney, D. B. Occurrence of antibiotics in hospital, residential and dairy effluent, municipal wastewater and the Rio Grande in New Mexikco. Sci. Total Environ. 2006, 366, 772-783.
53. Karthikeyan, K. G.; Meyer, M. T. Occurrence of antibiotics in wastewater treatment facilities in Wisconsin, USA. Sci. Total Environ. 2006, 361, 196-207.
54. Levine, A. D.; Meyer, M. T.; Kish, G. Evaluation of the persistence of micropollutants through pure-oxygen activated sludge nitrification and denitrification. Water Environ. Res. 2006, 78, 2276-2285.
55. Batt, A. L.; Kim, S.; Aga, D. S. Comparison of the occurrence of antibiotics in four full-scale wastewater treamtent plants with varying designs and operations. Chemosphere 2007, 68, 428-435.
56. Watkinson, A. J.; Murby, E. J.; Costanzo, S. D. Removal of antibiotics in conventional and advanced wastewater treatment: Implications for environmental discharge and wastewater recycling. Water Res. 2007, 41, 4164-4176.
57. Ghosh, G. C.; Okuda, T.; Yamashita, N.; Tanaka, H. Occurrence and elimination of antibiotics at four sewage treatment plants in Japan and their effects on bacterial ammonia oxidation. Water Sci. Technol. 2009, 59, 779-786.
58. Gulkowska, A.; Leung, H. W.; So, M. K.; Taniyasu, S.; Yamashita, N.; Yeung, L. W. Y.; Richardson, B. J.; Lei, A. P.; Giesy, J. P.; Lam, P. K. S. Removal of antibiotics from wastewater by sewage treatment facilities in Hong Kong and Shenzhen, China. Water Res. 2008, 42, 395-403.
59. Plósz, B. G.; Leknes, H.; Liltved, H.; Thomas, K. V. Diurnal variations in the occurrence and the fate of hormones and antibiotics in activated sludge wastewater treatment in Oslo, Norway. Sci. Total Environ. 2010, 408, 1915-1924.
60. Fick, J.; Lindberg, R. H.; Kaj, L.; Brorström-Lundén, E. Results from the Swedish National Screening Programme 2010, Subreport 3, Pharmaceuticals, B2014; Swedish Environmental Research Institute (IVL): Stockholm, Sweden, 2011. Available online: http://www. ivl. se (accessed on 12 March 2013).
61. Lacey, C.; Basha, S.; Morrissey, A.; Tobin, J. M. Occurrence of pharmaceutical compounds in wastewater process streams in Dublin, Ireland. Environ. Monit. Assess. 2012, 184, 1049-1062.
62. Leung, H. W.; Minh, T. B.; Murphy, M. B.; Lam, J. C. W.; So, M. K.; Martin, M.; Lam, P. K. S.; Richardson, B. J. Distribution, fate and risk assessment of antibiotics in sewage treatment plants in Hong Kong, South China. Environ. Int. 2012, 24, 1-9.
63. Lin, A. Y.-C.; Tsai, Y.-T.; Yu, T.-H.; Wang, X.-H.; Lin, C.-F. Occurrence and fate of pharmaceuticals and personal care products in Taiwan's aquatic environment. Desalin. Water Treat. 2012, 32, 57-64.
64. Verlicchi, P.; Al Aukidy, M.; Galletti, A.; Petrovič, M.; Barceló, D. Hospital effluent: Investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment. Sci. Total Environ. 2012, 430, 109-118.
65. Lam, M. W.; Young, C. J.; Brain, R. A.; Johnson, D. J.; Hanson, M. A.; Wilson, C. J.; Richards, S. M.; Solomon, K. R.; Mabury, S. A. Aquatic persistence of eight pharmaceuticals in a microcosm study. Environ. Sci. Technol. 2004, 23, 1431-1440.
66. Michael, I.; Hapeshi, E.; Osorio, V.; Perez, S.; Petrovič, M.; Zapata, A.; Malato, S.; Barceló, D.; Fatta-Kassinos, D. Solar photocatalytic treatment of trimethoprim in four environmental matrices at a pilot scale: Transformation products and ecotoxicity evaluation. Sci. Total Environ. 2012, 430, 167-173.
67. Boxall, A. B. A.; Fogg, L.; Blackwell, P. A.; Kay, P.; Pemberton, E. J. Review of Veterinary Medicines in the Environment. R&D Technical Report P6-012/8/TR, Environment Agency, Bristol, UK, 2002; p. 187; Available online: http://a0768b4a8a31e106d8b0-50dc802554eb38a 24458b98ff72d550b. r19. cf3. rackcdn. com/sp6-012-8-tr-e-e. pdf (accessed on 12 March 2013).
68. Boxall, A. B. A.; Fogg, L. A.; Blackwell, P. A.; Kay, P.; Pemberton, E. J.; Croxford, A. Veterinary medicines in the environment. Rev. Environ. Contam. Toxicol. 2004, 180, 1-91.
69. Lunestad, B. T.; Samuelsen, O. B.; Fjelde, S.; Ervik, A. Photostability of 8 antibacterial agents in seawater. Aquaculture 1995, 134, 217-225.
70. Türk, J. Entwicklung und Anwendung von LC-MS/MS Multimethoden zur Bestimmung von Antibiotika und Zytostatika bei Arbeitsschutz-und Umweltuntersuchungen. Ph. D. Thesis, Universität Duisburg-Essen, Germany, 2007. Available online: http://duepublico. uni-duisburg-essen. de/servlets/DerivateServlet/Derivate-17529/Tuerk_Dissertation_070831. pdf (accessed on 12 March 2013).
71. Rosario-Ortiz, F.; Wert, E. C.; Snyder, S. A. Evaluation of UV/H2O2 treatment for the oxidation of pharmaceuticals in wastewater. Water Res. 2010, 44, 1440-1448.
72. Wu, Y.; Chen, D.-H.; Kookana, R. Aqueous photodegradation of selected antibiotics under different conditions. Energy Procedia 2011, 11, 2098-2103.
73. Zuccato, E.; Bagnati, R.; Fioretti, F.; Natangelo, M.; Calamari, D.; Fanelli, R. Environmental loads and detection of pharmaceuticals in Italy. In Pharmaceuticals in the Environment; Kümmerer, K., Ed.; Springer: Berlin, Germany, 2001; pp. 19-27.
74. Hektoen, H.; Berge, J. A.; Hormabazal, V.; Ydnestad, M. Persistence of antiobacterial agents in marine sediments. Aquaculture 1995, 133, 175-184.
75. Möhle, E.; Metzger, J. W. Drugs in Municipal Sewage Effluents: Screening and Biodegradation Studies. In Pharmaceuticals and Personal Care Products in the Environment; Scientific and Regulatory Issues, ACS Symposium Series 791; Daughton, C. G., Jones-Lepp, T. L., Eds.; American Chemical Society: Washington, DC, USA, 2001; pp. 192-205.
76. Le-Minh, N.; Khan, S. J.; Drewes, J. E.; Stuetz, R. M. Fate of antibiotics during municipal water recycling treatment processes. Water Res. 2010, 44, 4295-4323.
77. Toot-Levy, E.; Foley, F.; Chapman Smith, J.; Granlund, K. Nothing to fear. Screening assessment heps Ohio utility put the risks of pharmaceuticals and personal care products in perspective. Water Environ. Technol. 2011, 23, 40-45.
78. Bondarenko, S.; Gan, J.; Ernst, F.; Green, R.; Baird, J.; McCullough, M. Leaching of pharmaceuticals and personal care products in trufgrass soils during recycled water irrigation. J. Environ. Quality 2012, 41, 1268-1274.
79. European Commission. Technical Guidance Document on Risk Assessment in Support of Commission Directive 93/67/EEC on Risk Assessment for New Notified Substances, Commission Regulation (EC) No 1488/94 on Risk Assessment for Existing Substances, Directive 98/8/EC of the European Parliament and of the Council concerning the Placing of Biocidal Products on the Market. European Union: Brussels, Belgium, 2003. Available online: http://ihcp. jrc. ec. europa. eu/our_activities/health-env/risk_assessment_of_Biocides/doc/tgd/(accessed on 12 March 2013).
80. Bergsjø, T.; Nafstad, I.; Ingebrigtsen, K. The distribution of 35S-sulfadiazine and 14C-trimethoprim in rainbow trout, Salmo gairdneri. Acta Vet. Scand. 1979, 20, 25-37.
81. Fang, X.-X.; Li, J.; Wang, Q.; Liu, X.-H. Residual characteristics of sulfamethoxazole and trimethoprim in Lateolabrax japonicus at different water temperature (in Chinese with English abstract). Marine Sci. 2003, 27, 16-20.
82. Ramirez, A. J.; Brain, R. A.; Usenko, S.; Mottaleb, M. A.; O'Donnell, J. G.; Stahl, L. L.; Wathen, J. B.; Snyder, B. D.; Pitt, J. L.; Perez-Hurtado, P.; et al. Occurrence of pharmaceuticals and personal care products in fish: Results of a national pilot study in the United States. Environ. Sci. Technol. 2009, 28, 2587-2597.
83. Herklotz, P. A.; Gurung, P.; Vanden Heuvel, B.; Kinney, C. A. Uptake of human pharmaceuticals by plants grown under hydroponic conditions. Chemosphere 2010, 78, 1416-1421.
84. Sabourin, L.; Duenk, P.; Bonte-Gelok, S.; Payne, M.; Lapen, D. R.; Topp, E. Uptake of pharmaceuticals, hormones and parabens into vegetables grown in soil fertilised with municipal biosolids. Sci. Total Environ. 2012, 431, 233-236.
85. Ternes, T. German Federal Institute for Water Research (BAfG), Koblenz, Germany. Personal Communication, 2011.
86. Note for Guidance on Environmental Risk Assessment of Medicinal Products for Human Use. CPMP/SWP/4447/00 corr 1. European Medicines Agency: London, UK, 2006. Available online: http://www. ema. europa. eu/docs/en_GB/document_library/Scientific_guideline/2009/10/WC500003978. pdf (accessed on 12 March 2013).
87. IMS Health/IMS MIDAS. Subscription online database for API use. Copyright IMS Health. TMP data downloaded on 18 January 2012.
88. Eurostat. Population in Europe 2000-2011; European Statistics Office: Brussels, Belgium, 2012. Available online: http://epp. eurostat. ec. europa. eu/tgm/download. do?tab=table&plugin=1&language =en&pcode=tps0000 (accessed on 17 January 2012).
89. ter Laak, T.; van der Aa, M.; Houtman, C.; Stoks, P.; van Wezel, A.; RIWA. Temporal and spatial trends of pharmaceuticals in the Rhine. Rhine Water Works, Nieuwegein, The Netherlands, 2010. Available online: http://www. riwa. org (accessed on 12 March 2013).
90. Hirsch, R.; Ternes, T.; Haberer, K.; Kratz, K.-L. Occurrence of antibiotics in the aquatic environment. Sci. Total Environ. 1999, 225, 109-118.
91. Sacher, F.; Gabriel, S.; Metzinger, M.; Stretz, A.; Wenz, M.; Lange, F.; Brauch, H.-J.; Blankenhorn, I. Arzneimittelwirkstoffe im Grundwasser-Ergebnisse eines Monitoring-Programms in Baden-Württemberg. Vom Wasser 2002, 99, 183-196.
92. AGRE (Arbeitsgemeinschaft für die Reinhaltung der Elbe). Arzneistoffe in Elbe und Saale; Ministerium für Landwirtschaft, Umweltschutz und Raumordnung des Landes Brandenburg: Potsdam, Germany, 2002.
93. BLAC (Bund/Länderausschuss für Chemikaliensicherheit). Arzneimittel in der Umwelt. Auswertung der Untersuchungsergebnisse. Bericht an die 61. Umweltministerkonferenz (UMK) am 19./20. November 2003 in Hamburg; Freie und Hansestadt Hamburg, Behörde für Umwelt und Gesundheit, Institut für Hygiene und Umwelt: Hamburg, Germany, 2003.
94. Christian, T.; Schneider, R. J.; Färber, H. A.; Skutlarek, D.; Meyer, M. T.; Goldbach, H. E. Determination of antibiotic residues in manure, soil and surface waters. Acta Hydrochim. Hydrobiol. 2003, 31, 36-44.
95. Christian, T. Antibiotika in Oberflächengewässern Nordrhein-Westfalens-Herkunft, Eintrag, Verbleib und Relevanz. Ph. D. Thesis, Rheinische Friedrich-Wilhelms-Universität, Bonn, Germany, 2004; Available online: http://hss. ulb. uni-bonn. de/2004/0476/0476. htm (accessed on 12 March 2013).
96. Wiegel, S.; Aulinger, A.; Brockmeyer, R.; Harms, H.; Löffler, J.; Reincke, H.; Schmidt, R.; Stachel, B.; von Trümpling, W.; Wanke, A. Pharmaceuticals in the river Elbe and its tributaries. Chemosphere 2004, 57, 107-126.
97. LANUV (Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen). Eintrag von Arzneimitteln und deren Verhalten und Verbleib in der Umwelt-Literaturstudie. LANUV-Fachbericht 2; Landesamt für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen: Recklinghausen, Germany, 2007; Available online: http://www. lanuv. nrw. de/veroeffentlichungen/lanuv/vls. htm (accessed on 12 March 2013).
98. Skutlarek, D. Analysenmethoden für Antibiotika und perfluorierte Tenside in wässrigen Matrizes mittels LC-MS/MS nach SPE-Anreicherung-Methodenentwicklung, Methodenvalidierung, Datenerhebung. Ph. D. Thesis, Ruprecht-Karls-Universität, Heidelberg, Germany, 2008. Available online: archiv. ub. uni-heidelberg. de/volltextserver/volltexte/2008/8922/pdf/Dissertation_Skutlarek_Dirk_2008. pdf (accessed on 12 March 2013).
99. HLUG (Hessisches Landesamt für Umwelt und Gesundheit). Arzneimittel in nordhessischen Fließgewässern 2007/2008/2009 und 2010; HLUG: Frankfurt, Germany, 2010; Available online: http://www. hlug. de/start/wasser/fliessgewaesser-chemie/spurenstoffe/arzneimittel. html (accessed on 12 March 2013).
100. HLUG (Hessisches Landesamt für Umwelt und Gesundheit). Arzneimittel in südhessischen Fließgewässern 2007/2008/2009 und 2010; HLUG: Frankfurt, Germany, 2010; Available online: http://www. hlug. de/start/wasser/fliessgewaesser-chemie/spurenstoffe/arzneimittel. html (accessed on 12 March 2013).
101. Lehmann, M. Messprogramme zu Arzneimitteln in Fließgewässern Baden-Württembergs. Presented at UBA-Workshop Monitoring Arzneimittel, Umweltbundesamt Dessau, Germany, 14-15 September 2011; Available online: http://www. umweltbundesamt. de/chemikalien/arzneimittel/workshop_monitoring_arzneimittel. htm (accessed 12 March 2013).
102. Skark, C. Monitoring von Arzneimitteln und organischen Spurenstoffen in der Ruhr. Presented at UBA-Workshop Monitoring Arzneimittel, Umweltbundesamt Dessau, Germany, 14-15 September 2011; Available online: http://www. umweltbundesamt. de/chemikalien/arzneimittel/workshop_monitoring_arzneimittel. htm (accessed 12 March 2013).
103. Triebskorn, R.; Hetzenauer, H. Mikroverunreinigungen in den drei Bodenseezuflüssen Argen, Schussen und Seefelder Aach-eine Literaturstudie. Environ. Sci. Eur. 2012, 24, doi: 10. 1186/2190-4715-24-8. Available online: http://www. enveurope. com/content/24/1/8 (accessed on 12 March 2013).
104. Tamtam, F.; Mercier, F.; Le Bot, B.; Eurin, J.; Dinh, Q. C.; Clément, M.; Chevreuil, M. Occurrence and fate of antibiotics in the Seine River in various hydrological conditions. Sci. Total Environ. 2008, 393, 84-95.
105. RIWA Rhein. Jahresbericht Rhein 2004-2010; RIWA-Rhein, Verband der Flusswasserwerke: Nieuwegein, The Netherlands, 2004-2010; Available online: http://www. riwa. org (accessed on 12 March 2013).
106. van Mill, G. M. J.; Verhoeven, B. M.; Rijs, G. B. J./RIZA. Monitoring geneesmiddelen en oestrogenen 2005; Waterschap Aa en Maas & Rijksinstituut voor Integraal Zoetwaterbeheer en Afvalwaterbehandeling (RIZA): Amsterdam, The Netherlands, 2006.
107. Muñoz, I.; López-Doval, J. C.; Ricart, M.; Villagrasa, M.; Brix, R.; Geiszinger, A.; Ginebreda, A.; Guasch, H.; López de Alda, M.; Romain, A. M.; et al. Bridging levels of pharmaceuticals in river water with biological community structure in the Llobregat river basin (northeast Spain). Environ. Chem. Toxicol. 2009, 28, 2706-2714.
108. Fernández, C.; González-Doncel, M.; Pro, J.; Carbonell, G.; Tarazona, J. V. Occurrence of pharmaceutically active compounds in surface waters of the Henare-Jarama-Tajo river system (Madrid, Spain) and a potential risk characterisation. Sci. Total Environ. 2009, 408, 543-551.
109. Valcárcel, Y.; González Alonso, S.; Rodríguez-Gil, J. L.; Gil, A.; Catalá, M. Detection of pharmaceutically active compounds in the rivers and tap water of the Madrid Region (Spain) and potential ecotoxicological risk. Chemosphere 2011, 84, 1336-1348.
110. López-Serna, R.; Postigo, C.; Blanco, J.; Pérez, S.; Ginebreda, A.; López de Alda, M.; Petrović, M.; Munné, A.; Barceló, D. Assessing the effects of tertiary treated wastewater reuse on the presence emerging contaminants in a Mediterranean river (Llobregat, NE Spain), Supporting Information. Environ. Sci. Pollut. Res. 2012, 19, 1000-1012.
111. Khalaf, H.; Salste, L.; Karlsson, P.; Ivarsson, P.; Jass, J.; Olsson, P.-E. In vitro analysis of inflammatory responses following environmental exposure to pharmaceuticals and inland waters. Sci. Total Environ. 2009, 407, 1452-1460.
112. Alder, A. C.; McArdell, C. S.; Giger, W.; Golet, E. M.; Molnar, E.; Nipales, N. S. Determination of Antibiotics in Swiss Wastewater and in Surface Water. Presented at the CIWEM East Anglian Region Conference on Antibiotics in the Environment, Cambridge, UK, 2 February 2000; Environment Agency: Bristol, UK, 2000.
113. Blüm, W.; McArdell, C. S.; Hoehn, E.; Schaubhut, R.; Labhart, W.; Bertschi, S. Organische Spurenstoffe im Grundwasser des Limmattales-Ergebnisse der Untersuchungskampagne 2004. In Zusammenarbeit mit EAWAG; Baudirektion Kanton Zürich, AWEL Amt für Abfall, Wasser, Energie und Luft: Zürich, Switzerland, 2005.
114. SG/AR/TG/GL Fliessgewässerüberwachung 2005: Bestimmung von Hormonen und Arzneimittelwirkstoffen in Fliessgewässern der Kantone SG, AR, TG und GL im Auftrag der Kantone. DVGW-Technologiezentrum Wasser (TZW): Karlsruhe, Germany, 2005.
115. Keller, A.; Balsiger, C. Risikobeurteilung von Arzneimitteln und endokrin wirksamen Substanzen in Oberflächengewässern des Kantons Zürich. Praktikumsbericht. Baudirektion Kanton Zürich, AWEL Amt für Abfall, Wasser, Energie und Luft: Zürich, Switzerland, 2007.
116. Bonvin, F.; Rutler, R.; Chèvre, N.; Halder, J.; Kohn, T. Spatial and temporal presence of a wastewater-derived micropollutant plume in Lake Geneva. Environ. Sci. Technol. 2011, 45, 4702-4709.
117. Ashton, D.; Hilton, M.; Thomas, K. V. Investigating the environmental transport of human pharmaceuticals to streams in the United Kingdom. Sci. Total Environ. 2004, 333, 167-184.
118. Roberts, P. H.; Thomas, K. V. The occurrence of selected pharmaceuticals in wastewater effluent and surface waters of the lower Tyne catchment. Sci. Total Environ. 2005, 356, 143-153.
119. Kasprzyk-Hordern, B.; Dinsdale, R. M.; Guwy, A. J. Multi-residue method for the determination of basic/neutral pharmaceuticals and illicit drugs in surface water by solid-phase extraction and ultra performance liquid chromatography-positive electrospray ionisation tandem mass spectrometry. J. Chromatogr. A 2007, 1161, 132-145.
120. Boxall, A. B. A.; Monteiro, S. C.; Fussell, R.; Williams, R. J.; Bruemer, J.; Greenwood, R.; Bersuder, P. Targeted Monitoring for Human Pharmaceuticals in Vulnerable Source and Final Waters. Drinking Water Inspectorate Project No. WD0805 (Ref DWI 70/2/231), December 2011. UK Department for Environment, Food and Rural Affairs: London, UK, 2012; Available online: http://dwi. defra. gov. uk/research/completed-research/reports/DWI70_2_231. pdf (accessed on 12 March 2013).
121. Straub, J. O. Matters of Fact and of Fiction: European PECs and MECs of Ibuprofen. Poster of the SETAC Europe 16th Annual Meeting, Hague, The Netherlands, 2006.
122. Straub, J. O. Deterministic and Probabilistic Environmental Risk Assessment for Diazepam. In Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks, 3rd ed.; Kümmerer, K., Ed.; Springer: Heidelberg, Germany, 2008; pp. 343-383.
123. Metcalfe, C. D.; Alder, A. C.; Halling-Sørensen, B.; Krogh, K.; Fenner, K.; Larsbo, M.; Straub, J. O.; Ternes, T. A.; Topp, E.; Lapen, D. R.; et al. Exposure Assessment Methods for Veterinary and Human Use Medicines in the Environment: PEC vs. MEC comparisons. In Pharmaceuticals in the Environment: Sources, Fate, Effects and Risks, 3rd ed.; Kümmerer, K., Ed.; Springer: Heidelberg, Germany, 2008; pp. 147-171.
124. Kolpin, D. W.; Furlong, E. T.; Meyer, M. T.; Thurman, E. M.; Zaugg, S. D.; Barber, L. B.; Buxton, H. T. Pharmaceuticals, hormones and other organic wastewater contaminants in US streams, 1999-2000: A national reconnaissance. Environ. Sci. Technol. 2002, 36, 1202-1211.
125. Bound, J. P.; Voulvoulis, N. Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United Kingdom. Environ. Health Persp. 2005, 113, 1705-1711.
126. Pharmaceuticals for Human Use: Options of Action for Reducing the Contamination of Water Bodies. A Practical Guide. START Project, ISOE: Frankfurt, Germany, 2008; Available online: http://www. start-project. de/downloads/start_Practical_Guide. pdf (accessed on 12 March 2013).
127. Musson, S. E; Townsend, T. G. Pharmaceutical compound content of municipal solid waste. J. Hazard. Mater. 2009, 162, 730-735.
128. Oggier, D. Trimethoprim, Test for Inhibition of Oxygen Consumption by Activated Sludge: Respiration Inhibition Test. BMG A11-00371. BMG Engineering on behalf of F. Hoffmann-La Roche Ltd: Schlieren, Switzerland, 2011; unpublished.
129. Blaise, C.; Gagné, F.; Eullafroy, P.; Férard, J.-F. Ecotoxicity of selected pharmaceuticals of urban origin discharged to the Saint-Lawrence river (Québec, Canada): A review. Braz. J. Aquat. Sci. Technol. 2006, 10, 29-51.
130. Kim, Y.; Choi, K.; Jung, J.; Park, S.; Kim, P.-G.; Park, J. Aquatic toxicity of acetaminophen, carbamazepine, cimetidine, diltiazem and six major sulfonamides, and their potential ecological risks in Korea. Environ. Int. 2007, 33, 370-375.
131. Isidori, M.; Lavorgna, M.; Nardelli, A.; Pascarella, L.; Parrella, A. Toxic and genotoxic evaluation of six antibiotics on non-target organisms. Sci. Total Environ. 2005, 346, 87-98.
132. Ciftcioglu, N.; Miller-Hjelle, M. A.; Hjelle, J. T.; Kajander, E. O. Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method. Antimicrob. Agents Chemother. 2002, 46, 2077-2086.
133. Tappe, W; Kummer, S.; Zielezny, Y.; Vereecken, H.; Groeneweg, J. Combined Effects of Sulfadiazine and Trimethoprim on Soil Bacteria. Poster of the 16th SETAC Europe Annual Meeting, Hague, The Netherlands, 7-11 May 2006.
134. Oggier, D. TMP Nitrification inhibition test ISO9509. BMG A11-00764; BMG Engineering on behalf of F. Hoffmann-La Roche Ltd: Schlieren, Switzerland, 2011; unpublished.
135. Liu, F.; Ying, G.-G.; Tao, R.; Zhao, J.-L.; Yang, J.-F.; Zhao, L.-F. Effects of six selected antibiotics on plant growth and soil microbial and enzymatic activities. Environ. Pollut. 2009, 157, 1636-1642.
136. Ando, T.; Nagase, H.; Eguchi, K.; Hirooka, T.; Nakamura, T.; Miyamoto, K.; Hirata, K. A novel method using cyanobacteria for ecotoxicity test of veterinary antimicrobial agents. Environ. Toxicol. Chem. 2007, 26, 601-606.
137. Claessens, M.; Wille, K.; Vanhaecke, L.; Noppe, H.; De Brabander, H.; Janssen, C. Occurrence and Effects of Pharmaceuticals in the Belgian Coastal Zone. Poster of the SETAC Europe 19th Annual Meeting, Göteborg, Sweden, 31 May to 4 June 2009.
138. Holten Lützhøft, H.-C.; Halling-Sørensen, B.; Jorgensen, S. E. Algal toxicity of antibacterial agents applied in Danish fish farming. Arch. Environ. Contam. Toxicol. 1999, 36, 1-6.
139. Yang, L.-H.; Ying, G.-G.; Su, H.-C.; Strauber, J. L.; Adams, M. S.; Binet, M. T. Growth-inhibiting effects of 12 antibacterial agents and their mixtures on the freshwater microalga Pseudokirchneriella subcapitata. Environ. Sci. Technol. 2008, 27, 1201-1208.
140. Eguchi, K.; Nagase, H.; Ozawa, M.; Enoh, Y. S.; Goto, K.; Hirata, K.; Miyamoto, K.; Yoshimura, H. Evaluation of antimicrobial agents for veterinary use in the ecotoxicity test using microalgae. Chemosphere 2004, 57, 1733-1738.
141. Bogers, R. Algal growth inhibition test with Trimethoprim, OECD 201. NOTOX b. v., on behalf of F. Hoffmann-La Roche Ltd: s-Hertogenbosch, The Netherlands, 1996; unpublished.
142. Brain, R. A.; Johnson, D. A.; Richards, S. M.; Sanderson, H.; Sibley, P. K.; Solomon, K. R. Effects of 25 pharmaceutical compounds to Lemna gibba using a seven-day static-renewal test. Environ. Sci. Technol. 2004, 23, 371-382.
143. Oggier, D. Trimethoprim, Growth inhibition test with Lemna minor. BMG A11-00372; BMG Engineering, on behalf of F. Hoffmann-La Roche Ltd: Schlieren, Switzerland, 2011, unpublished.
144. Quinn, B.; Gagné, F.; Blaise, C. The effects of pharmaceuticals on regeneration of the cnidarian, Hydra attenuata. Sci. Total Environ. 2008, 402, 62-69.
145. Rhee, J.-S.; Jeong, C.-B.; Kim, B.-M.; Lee, J.-S. P-glycoprotein (P-gp) in the monogonont rotifer, Brachionus koreanus: Molecular characterization and expression in response to pharmaceuticals. Aquat. Toxicol. 2012, 114-115, 104-118.
146. Park, S.; Choi, K. Hazard assessment of commonly used agricultural antibiotics on aquatic ecosystems. Ecotoxicology 2008, 17, 526-538.
147. Bogers, R. Daphnid immobilisation test with Trimethoprim, OECD 202. NOTOX b. v., on behalf of F. Hoffmann-La Roche Ltd.: s-Hertogenbosch, The Netherlands, 1996; unpublished.
148. De Liguoro, M.; Fioretto, B.; Poltronieri, C.; Gallina, G. The toxicity of sulfamethazine to Daphnia magna and its additivity to other veterinary sulfanomides and trimethoprim. Chemosphere 2009, 75, 1519-1524.
149. Iannacone, J.; Alvariño, L. Evaluación del riesgo acuático de siete productos farmacéuticos sobre Daphnia magna. Ecología aplicada 2009, 8, 71-80.
150. Choi, K.; Kim, Y.; Jung, J.; Kim, M.-H.; Kim, C.-S.; Kim, N.-H.; Park, J. Occurrences and ecological risk of roxithromycin, trimethoprim and chloramphenicol in the Han river, Korea. Environ. Sci. Technol. 2008, 27, 711-719.
151. Quinn, B.; Gagné, F.; Blaise, C. An investigation into the acute and chronic toxicity of eleven pharmaceuticals (and their solvents) found in wastewater effluent on the cnidarian, Hydra attenuata. Sci. Total Environ. 2008, 389, 306-314.
152. Flaherty, C.; Dodson, S. I. Effects of pharmaceuticals on Daphnia survival, growth and reproduction. Chemosphere 2005, 61, 200-207.
153. Gilberg, D.; Hamberger, R. Trimethoprim: a study on the toxicity to early-life stages of zebrafish according to OECD Guideline No. 210 "Fish, Early-life stage Toxicity Test". ECT Oekotoxikologie GmbH, Flörsheim/Main, Germany and CIP Chemisches Institut Pforzheim GmbH, on behalf of F. Hoffmann-La Roche Ltd: Pforzheim, Germany, 2011; unpublished.
154. Richards, S. M.; Cole, S. E. A toxicity and hazard assessment of fourteen pharmaceuticals to Xenopus laevis larvae. Ecotoxicology 2006, 15, 647-656.
155. Technical Guidance for Deriving Environmental Quality Standards. Common Implementation Strategy for the Water Framework Directive (2000/60/EC), Guidance Document No. 27. European Communities, Brussels, Belgium, 2011; Available online: http://ec. europa. eu (accessed on 12 March 2013).
156. Binelli, A.; Parolini, M.; Cogni, D.; Pedriali, A.; Provini, A. A multi-biomarker assessment of the impact of the antibacterial trimethoprim on the non-target organism zebra mussel (Dreissena polymorpha). Comp. Biochem. Physiol. C 2009, 150, 329-336.
157. Escher, B. I.; Hermens, J. L. M. Internal exposure: Linking bioavailability to effects. Environ. Sci. Technol. 2004, 38, 455A-462A.
158. DEFRA/Hart, A.; Roelofs, W. Webfram pesticide risk assessment tool. Framework for Addressing Uncertainty and Variability in Pesticide Risk Assessment, Developed on behalf of DEFRA: London, UK. Available online: http://www. webfram. com (accessed on 12 March 2013).
159. Roelofs, W. DEFRA, London, UK. Personal Communication, 2008.
160. Kortenkamp, A.; Backhaus, T.; Faust, M. State of the Art Report on Mixture Toxicity. Final Report. Study Contract Number 070307/2007/485103/ETU/D. 1. The School of Pharmacy, University of London: London UK, 2009. Available online: http://ec. europa. eu/environment/chemicals/pdf/report_Mixture%20toxicity. pdf (accessed on 12 March 2013).
161. DANMAP. Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. Statens Serum Institute, Copenhagen, Denmark, 2010/2011. Available online: http://www. danmap. org/Downloads/~/media/Projekt%20sites/Danmap/DANMAP%20reports/Danmap_2010. ashx (accessed on 23 July 2012).
162. Martínez, J. L. Environmental pollution by antibiotics and by antibiotic resistance determinants. Environ. Pollut. 2009, 157, 2893-2902.
163. La Para, T. M.; Burch, T. R.; McNamara, P. J.; Tan, D. T.; Yan, M.; Eichmiller, J. J. Tertiary-treated municipal wastewater is a significant point source of antibiotic resistance genes into Duluth-Superior Harbor. Environ. Sci. Technol. 2011, 45, 9453-9459.
164. Czekalski, N.; Berthold, T.; Caucci, S.; Bürgmann, H. Increased levels of multiresistant bacteria and resistance genes after wastewater treatment and their dissemination into Lake Geneva, Switzerland. Frontiers Microbiol. 2012, 3, doi: 10. 3389/fmicb. 2012. 00106.
165. Forsberg, K. J.; Reyes, A.; Wang, B.; Selleck, E. M.; Sommer, M. O. A.; Dantas, G. The shared antibiotic resistome of soil bacteria and human pathogens. Science 2012, 337, 1107-1111.
166. Al-Ahmad, A.; Haiss, A.; Unger, J.; Brunswick-Tietze, A.; Wiethan, J.; Kümmerer, K. Effects of a realistic mixture of antibiotics on resistant and nonresistant sewage sludge bacteria in laboratory-scale treatment plants. Arch. Environ. Contam. Toxicol. 2009, 57, 264-273.